Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Details
Structural aspects of Mycobacterium tuberculosis DNA gyrase targeted by novel bacterial topoisomerase inhibitors
ID
Kokot, Maja
(
Author
),
ID
Hrast, Martina
(
Author
),
ID
Feng, Lipeng
(
Author
),
ID
Mitchenall, Lesley A
(
Author
),
ID
Lawson, David M.
(
Author
),
ID
Maxwell, Anthony
(
Author
),
ID
Parish, Tanya
(
Author
),
ID
Minovski, Nikola
(
Author
),
ID
Anderluh, Marko
(
Author
)
PDF - Presentation file,
Download
(6,47 MB)
MD5: F9AE93CDB8CB4E1CEA8BA539B1EA29F5
URL - Source URL, Visit
https://pubs.acs.org/doi/10.1021/acsmedchemlett.4c00447
Image galllery
Abstract
In this Letter, we present a small series of novel bacterial topoisomerase inhibitors (NTBIs) that exhibit both potent inhibition of Mycobacterium tuberculosis DNA gyrase and potent antimycobacterial activity. The disclosed crystal structure of M. tuberculosis DNA gyrase in complex with DNA and compound 5 from this NBTI series reveals the binding mode of an NBTI in the GyrA binding pocket and confirms the presence and importance of halogen bonding for the excellent on-target potency. In addition, we have shown that compound 5 is a promising M. tuberculosis DNA gyrase inhibitor, with an IC$_{50}$ for M. tuberculosis gyrase of 0.096 μM, and it has potent activity against M. tuberculosis, with an IC$_{50}$ of 0.165 μM.
Language:
English
Keywords:
NBTIs
,
DNA gyrase
,
M. tuberculosis
,
crystal structure
,
bifurcated halogen bonds
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
Str. 2164−2170
Numbering:
Vol. 15, iss. 12
PID:
20.500.12556/RUL-165967
UDC:
615.4:54:616-002.5
ISSN on article:
1948-5875
DOI:
10.1021/acsmedchemlett.4c00447
COBISS.SI-ID:
215946755
Publication date in RUL:
16.12.2024
Views:
229
Downloads:
77
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
ACS Medicinal Chemistry Letters
Publisher:
American Chemical Society
ISSN:
1948-5875
COBISS.SI-ID:
2959217
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
DNA giraza
,
Mycobacterium tuberculosis
,
inhibitorji
,
bakterijske topoizomeraze
,
farmacevtska kemija
,
tuberkuloza
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0017
Name:
Modeliranje kemijskih procesov in lastnosti spojin
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARRS - Slovenian Research Agency
Funding programme:
Young researchers
Project number:
39010
Funder:
UKRI - UK Research and Innovation
Funding programme:
Biotechnology and Biosciences Research Council, Institute Strategic Programme
Project number:
BB/P012523/1
Funder:
UKRI - UK Research and Innovation
Funding programme:
Biotechnology and Biological Sciences Research Council
Project number:
BB/V006983/1
Funder:
ARRS - Slovenian Research Agency
Project number:
BI-US/22-25-151
Funder:
NIH - National Institutes of Health
Funding programme:
National Institute of Allergy and Infectious Diseases
Project number:
P30AI168034
Name:
Seattle Tuberculosis Research Advancement Center
Acronym:
SEATRAC
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back